|
Wednesday, January 18, 2017 |
|
雅各臣收购「十灵丹」、「十灵油」及「伤风克」建立具扩展性平台 |
从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业-雅各臣科研制药有限公司(「雅各臣」或「集团」;股份代号:2633)今天公布收购一系列家喻户晓的药品品牌,包括「十灵丹」、「十灵油」及「伤风克」。 more info >> |
|
雅各臣收購「十靈丹」、「十靈油」及「傷風克」建立具擴展性平台 |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業-雅各臣科研製藥有限公司(「雅各臣」或「集團」;股份代號:2633)今天公佈收購一系列家喻戶曉的藥品品牌,包括「十靈丹」、「十靈油」及「傷風克」。 more info >> |
|
Jacobson Pharma to Acquire Saplingtan, Shiling Oil & Col-gan Tablet; Creating an Expandable Proprietary Medicine Platform |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its acquisition of a family of popular household brands, namely, Saplingtan, Shiling Oil and Col-gan Tablet. more info >> |
|
Tuesday, December 13, 2016 |
|
Jacobson Pharma Announces Acquisition of 100% Interest in Ho Chai Kung Brand |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary Chinese medicines, today announces the acquisition of 100% interest in a Target Group (comprising "Karen Pharmaceutical Company Limited" more info >> |
|
Wednesday, November 23, 2016 |
|
雅各臣公布二零一六年中期业绩 |
从事非专利药及中成药研发、生产、市场推广及销售的领先企业,以及香港最大的非专利药公司─雅各臣科研制药有限公司(「雅各臣」或「公司」;股份代号:2633 )今天公布公司及附属公司(统称「集团」)截至二零一六年九月三十日止六个月(「报告期」)的未经审核中期业绩。 more info >> |
|
雅各臣公佈二零一六年中期業績 |
從事非專利藥及中成藥研發、生產、市場推廣及銷售的領先企業,以及香港最大的非專利藥公司─雅各臣科研製藥有限公司(「雅各臣」或「公司」;股份代號:2633)今天公佈公司及附屬公司(統稱「集團」)截至二零一六年九月三十日止六個月(「報告期」)的未經審核中期業績。 more info >> |
|
Jacobson Pharma Announces 2016 Interim Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development more info >> |
|
Monday, October 31, 2016 |
|
雅各臣完成收购香港一家具信誉的非专利药制造商 |
从事非专利药及中成药研发、生产、市场推广及销售的领先企业,以及香港最大的非专利药公司—雅各臣科研制药有限公司(「雅各臣」或「集团」;股份代号:2633)今天宣布完成收购Cawah Holdings Limited(「Cawah Holdings」)及其附属公司美达药厂有限公司(「美达药厂」),彼为香港一家具信誉的非专利药制造商,总代价为100,000,000港元。 more info >> |
|
雅各臣完成收購香港一家具信譽的非專利藥製造商 |
從事非專利藥及中成藥研發、生產、市場推廣及銷售的領先企業,以及香港最大的非專利藥公司—雅各臣科研製藥有限公司(「雅各臣」或「集團」;股份代號:2633)今天宣佈完成收購Cawah Holdings Limited(「Cawah Holdings」)及其附屬公司美達藥廠有限公司(「美達藥廠」),彼為香港一家具信譽的非專利藥製造商,總代價為100,000,000港元。 more info >> |
|
Jacobson Pharma Completes Acquisition of Reputable Generic Drug Manufacturer in Hong Kong |
Jacobson Pharma Corporation Limited today announces the completion of the acquisition of Cawah Holdings Limited ("Cawah Holdings") and its subsidiary namely, Medipharma Limited ("Medipharma") which is a reputable generic drug manufacturer in Hong Kong, at a total consideration of HK$100,000,000. more info >> |
|
|
|